secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001558370-24-001542
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Biosciences appoints Georgia Erbez to Board of Directors
----------------------------------------------------------------

- Board expanded from 9 to 10 directors; Erbez appointed as Class III director until 2026 annual meeting.
- Erbez also named to audit committee; has served as Managing Director of Axiom Financial Partners since 2014.
- Non-employee director: receives $50,000 annual cash retainer and option to purchase 54,000 shares vesting over 3 years.
- Previous roles include CFO of Harpoon Therapeutics and COO of Walking Fish Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024001542/0001558370-24-001542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024001542/chrs-20240220x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-001542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer